BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
Over the last two decades, significant progress has been made in cancer therapeutics, but significant challenges remain. At the BIO CEO and Investor Digital Conference, experts from leading companies discussed key issues such as. how to drive innovation in oncology, spotting the right investment, the future of PD-1 therapies, and emerging game changers in the field.
Driving Innovation in Oncology: Internal vs. External Pipelines
To drive innovation, Eli Lilly is going after compelling science. Its mantra for getting innovative cancer treatment is “going after actionable targets where there is a clear unmet need based on the current standard of care,” says Avnish Kapoor, Director, Emerging Technology and Innovation
Driving Innovation in Oncology: Internal vs. External Pipelines
To drive innovation, Eli Lilly is going after compelling science. Its mantra for getting innovative cancer treatment is “going after actionable targets where there is a clear unmet need based on the current standard of care,” says Avnish Kapoor, Director, Emerging Technology and Innovation
It's free! Log in now to read
LATEST
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115